Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients-Reference-Cited by-同舟云学术

Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients

Published:2007-12-15 Issue:11 Volume:84 Page:1443-1451
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Bolin Paul,Tanriover Bekir,Zibari Gazi B.,Lynn Melissa L.,Pirsch John D.,Chan Laurence,Cooper Matthew,Langone Anthony J.,Tomlanovich Stephen J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.;Sollinger;Transplantation,1995

2. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation.;Transplantation,1996

3. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection.;Lancet,1995

4. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.;Ojo;Transplantation,2000

5. Long-term use of mycophenolate mofetil is associated with a reduction in the incidence and risk of late rejection.;Meier-Kriesche;Am J Transplant,2003

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for living donor kidney transplantation;Nefrología (English Edition);2022-12

2. Recomendaciones para el trasplante renal de donante vivo;Nefrología;2022-04

3. Immunosuppressive therapy in SLE;Lahita's Systemic Lupus Erythematosus;2021

4. Therapeutic drug monitoring of mycophenolate mofetil in pediatric patients: novel techniques and current opinion;Expert Opinion on Drug Metabolism & Toxicology;2020-11-08

5. Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?;Drugs in R&D;2018-11-13